C3AR1 and Alzheimer disease: The mRNA expression of C3 and its receptor C3aR are upregulated in AD patients with tauopathy, and C3aR ablation attenuates tau pathology and reverses neuroinflammation in a tau-transgenic mouse AD model [25].